Yahoo
OTC Markets OTCPK USD

Aridis Pharmaceuticals, Inc. (ARDS)

0.0002 0.0000 (0.00%)
At close: October 30 at 4:00:00 PM EDT
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2022
12/31/2021
Total Revenue
19,602
0
0
Operating Expense
20,485
29,993
42,711
Operating Income
-883
-29,993
-42,711
Net Non Operating Interest Income Expense
177
-121
-245
Other Income Expense
-436
-257
763
Pretax Income
-1,142
-30,371
-42,193
Net Income Common Stockholders
-1,142
-30,371
-46,320
Diluted NI Available to Com Stockholders
-1,142
-30,371
-46,320
Basic EPS
-0.12
-1.62
-3.85
Diluted EPS
-0.16
-1.62
-3.85
Basic Average Shares
32,172.7380
18,777.3350
12,291.6000
Diluted Average Shares
40,885.3660
18,777.3350
12,291.6000
Total Operating Income as Reported
-883
-29,993
-42,711
Total Expenses
20,485
29,993
42,711
Net Income from Continuing & Discontinued Operation
-1,142
-30,371
-42,193
Normalized Income
-1,142
-30,371
-42,915
Net Interest Income
177
-121
-245
EBIT
-883
-29,993
-42,711
EBITDA
-574
-29,506
-42,276
Reconciled Depreciation
309
487
435
Net Income from Continuing Operation Net Minority Interest
-1,142
-30,371
-42,193
Total Unusual Items Excluding Goodwill
0
0
722
Total Unusual Items
0
0
722
Normalized EBITDA
-574
-29,506
-42,998
Tax Rate for Calcs
0
0
0
Tax Effect of Unusual Items
0
0
0
12/31/2021 - 8/14/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: